We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
126
CALL
Centene
CNC
$33.1B
$3M 0.11%
+50,000
New +$3.18M
HZNP
127
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.93M 0.11%
40,000
-50,000
-56% -$3.72M
HOLX
128
PUT
DELISTED
Hologic
HOLX
$2.91M 0.11%
+40,000
New +$2.82M
VTGN icon
129
VistaGen Therapeutics
VTGN
$11.6M
$2.83M 0.1%
+48,611
New +$1.24M
WGS icon
130
GeneDx Holdings
WGS
$2.46B
$2.65M 0.1%
+7,273
New +$2.53M
AVDL
131
DELISTED
Avadel Pharmaceuticals
AVDL
$2.6M 0.09%
389,571
-405,629
-51% -$2.54M
NVRO
132
CALL
DELISTED
NEVRO CORP.
NVRO
$2.6M 0.09%
+15,000
New +$2.43M
BCAB icon
133
BioAtla
BCAB
$5.61M
$2.6M 0.09%
+1,526
New +$2.55M
GH icon
134
CALL
Guardant Health
GH
$22.2B
$2.58M 0.09%
+20,000
New +$2.3M
ARVN icon
135
Arvinas
ARVN
$580M
$2.55M 0.09%
+30,000
New +$1.03M
KURA icon
136
Kura Oncology
KURA
$882M
$2.48M 0.09%
75,800
-26,266
-26% -$923K
CELL
137
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.38M 0.09%
+26,600
New +$2.24M
FBRX icon
138
Forte Biosciences
FBRX
$1.57B
$2.37M 0.09%
+2,600
New +$2.44M
XENT
139
CALL
DELISTED
Intersect ENT, Inc
XENT
$2.29M 0.08%
+100,000
New +$1.9M
FVAM
140
DELISTED
5:01 Acquisition Corp
FVAM
$2.22M 0.08%
+218,000
New +$2.2M
MRTX
141
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.2M 0.08%
+10,000
New +$2.16M
AMRS
142
DELISTED
Amyris Inc.
AMRS
$2.16M 0.08%
+350,000
New +$1.12M
SPRY icon
143
ARS Pharmaceuticals
SPRY
$601M
$2.08M 0.08%
+45,000
New +$1.5M
PHAT icon
144
Phathom Pharmaceuticals
PHAT
$742M
$1.99M 0.07%
+60,000
New +$2.43M
LOGC
145
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.91M 0.07%
+250,000
New +$1.67M
ZYXI
146
PUT
DELISTED
Zynex
ZYXI
$1.8M 0.07%
+147,070
New +$1.91M
CRDF icon
147
Cardiff Oncology
CRDF
$77.1M
$1.8M 0.07%
+100,000
New +$1.76M
ALPN
148
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.73M 0.06%
+137,108
New +$1.35M
SENS icon
149
Senseonics Holdings Inc
SENS
$419M
$1.7M 0.06%
+97,500
New +$849K
MORF
150
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.68M 0.06%
+50,000
New +$1.48M
4 5
6
7 8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.